Solar flair.
暂无分享,去创建一个
M. Stampfer | J. Garbe | Jee Hyung Lee | S. Haney | J. Manuel | S. Jelinsky | M. Whitley | Yizheng Li | C. Tunkey | Jian-Liang Li | Jing Pan | K. Saraf
[1] M. Stampfer. Cholera toxin stimulation of human mammary epithelial cells in culture , 1982, In Vitro.
[2] V. Tsikitis,et al. Biology of Ductal Carcinoma in Situ Classification Based on Biologic Potential , 2006, American journal of clinical oncology.
[3] G. Evan,et al. Reversible kinetic analysis of Myc targets in vivo provides novel insights into Myc-mediated tumorigenesis. , 2006, Cancer research.
[4] Howard Y. Chang,et al. Genetic regulators of large-scale transcriptional signatures in cancer , 2006, Nature Genetics.
[5] Gavin D. Grant,et al. Common markers of proliferation , 2006, Nature Reviews Cancer.
[6] P. Hall,et al. An expression signature for p53 status in human breast cancer predicts mutation status, transcriptional effects, and patient survival. , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[7] J. Campisi,et al. Caspase‐independent cytochrome c release is a sensitive measure of low‐level apoptosis in cell culture models , 2005, Aging cell.
[8] I. Poola,et al. Identification of MMP-1 as a putative breast cancer predictive marker by global gene expression analysis , 2005, Nature Medicine.
[9] T. Barrette,et al. Mining for regulatory programs in the cancer transcriptome , 2005, Nature Genetics.
[10] S. Ghosh,et al. Regulating Inducible Transcription Through Controlled Localization , 2005, Science's STKE.
[11] Yudong D. He,et al. A cell proliferation signature is a marker of extremely poor outcome in a subpopulation of breast cancer patients. , 2005, Cancer research.
[12] Martha R. Stampfer,et al. Chromatin Inactivation Precedes De Novo DNA Methylation during the Progressive Epigenetic Silencing of the RASSF1A Promoter , 2005, Molecular and Cellular Biology.
[13] S. Byers,et al. Oncogene-induced basement membrane invasiveness in human mammary epithelial cells , 1994, Clinical & Experimental Metastasis.
[14] Stanley N Cohen,et al. Disparate effects of telomere attrition on gene expression during replicative senescence of human mammary epithelial cells cultured under different conditions , 2004, Oncogene.
[15] B. Henderson,et al. BARD1 regulates BRCA1 apoptotic function by a mechanism involving nuclear retention. , 2004, Experimental cell research.
[16] K. Chin,et al. In situ analyses of genome instability in breast cancer , 2004, Nature Genetics.
[17] Jill P. Mesirov,et al. GeneCluster 2.0: an advanced toolset for bioarray analysis , 2004, Bioinform..
[18] S. Hankinson,et al. Insulin-like growth factors and neoplasia , 2004, Nature Reviews Cancer.
[19] E. Liu,et al. BRCA1 Interacts with and Is Required for Paclitaxel-Induced Activation of Mitogen-Activated Protein Kinase Kinase Kinase 3 , 2004, Cancer Research.
[20] David Botstein,et al. Different gene expression patterns in invasive lobular and ductal carcinomas of the breast. , 2004, Molecular biology of the cell.
[21] E. Montgomery,et al. Telomere Length Abnormalities Occur Early in the Initiation of Epithelial Carcinogenesis , 2004, Clinical Cancer Research.
[22] T. Tuttle,et al. Trends in the treatment of ductal carcinoma in situ of the breast. , 2004, Journal of the National Cancer Institute.
[23] Z. Weng,et al. Detection of functional DNA motifs via statistical over-representation. , 2004, Nucleic acids research.
[24] Cynthia A Afshari,et al. Histologically normal human mammary epithelia with silenced p16(INK4a) overexpress COX-2, promoting a premalignant program. , 2004, Cancer cell.
[25] N. Bundred,et al. COX-2 expression is associated with an aggressive phenotype in ductal carcinoma in situ , 2004, British Journal of Cancer.
[26] P. Yaswen,et al. Loss of p53 function accelerates acquisition of telomerase activity in indefinite lifespan human mammary epithelial cell lines , 2003, Oncogene.
[27] L. Murphy,et al. Psoriasin (S100A7) expression is associated with poor outcome in estrogen receptor-negative invasive breast cancer. , 2003, Clinical cancer research : an official journal of the American Association for Cancer Research.
[28] P. Yaswen,et al. Human epithelial cell immortalization as a step in carcinogenesis. , 2003, Cancer letters.
[29] M. West,et al. Gene expression predictors of breast cancer outcomes , 2003, The Lancet.
[30] A. Seth,et al. Gene expression profiling of ductal carcinomas in situ and invasive breast tumors. , 2003, Anticancer research.
[31] Manel Esteller,et al. Methylation of p16(INK4a) promoters occurs in vivo in histologically normal human mammary epithelia. , 2003, Cancer research.
[32] Kornelia Polyak,et al. Molecular markers in ductal carcinoma in situ of the breast. , 2003, Molecular cancer research : MCR.
[33] E. Wingender,et al. MATCH: A tool for searching transcription factor binding sites in DNA sequences. , 2003, Nucleic acids research.
[34] K. Chew,et al. Methylation of p 16 INK 4 a Promoters Occurs in Vivo in Histologically Normal Human Mammary Epithelia 1 , 2003 .
[35] D. Slonim. From patterns to pathways: gene expression data analysis comes of age , 2002, Nature Genetics.
[36] Jaejoon Won,et al. Sp1 and Sp3 Recruit Histone Deacetylase to Repress Transcription of Human Telomerase Reverse Transcriptase (hTERT) Promoter in Normal Human Somatic Cells* , 2002, The Journal of Biological Chemistry.
[37] John D. Watson,et al. Identifying Genes Regulated in a Myc-dependent Manner* , 2002, The Journal of Biological Chemistry.
[38] Jayanta Debnath,et al. The Role of Apoptosis in Creating and Maintaining Luminal Space within Normal and Oncogene-Expressing Mammary Acini , 2002, Cell.
[39] D. Haber,et al. BRCA1 Regulates the Interferon γ-mediated Apoptotic Response* , 2002, The Journal of Biological Chemistry.
[40] H. Avraham,et al. A Novel Tricomplex of BRCA1, Nmi, and c-Myc Inhibits c-Myc-induced Human Telomerase Reverse Transcriptase Gene (hTERT) Promoter Activity in Breast Cancer* , 2002, The Journal of Biological Chemistry.
[41] M. King,et al. BRCA1 transcriptionally regulates genes involved in breast tumorigenesis , 2002, Proceedings of the National Academy of Sciences of the United States of America.
[42] T. Volkert,et al. E2F integrates cell cycle progression with DNA repair, replication, and G(2)/M checkpoints. , 2002, Genes & development.
[43] D. Haber,et al. BRCA1 regulates the interferon gamma-mediated apoptotic response. , 2002, The Journal of biological chemistry.
[44] Alexander E. Kel,et al. MATCHTM: a tool for searching transcription factor binding sites in DNA sequences , 2003, Nucleic Acids Res..
[45] D. Slonim,et al. Evaluation of normalization procedures for oligonucleotide array data based on spiked cRNA controls , 2001, Genome Biology.
[46] R. Tibshirani,et al. Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[47] R. Schreiber,et al. Overexpression of IRF9 confers resistance to antimicrotubule agents in breast cancer cells. , 2001, Cancer research.
[48] M. Byrne,et al. Preparation of mRNA for Expression Monitoring , 2001, Current protocols in neuroscience.
[49] R. Donato,et al. S100: a multigenic family of calcium-modulated proteins of the EF-hand type with intracellular and extracellular functional roles. , 2001, The international journal of biochemistry & cell biology.
[50] P. Yaswen,et al. Expression of the telomerase catalytic subunit, hTERT, induces resistance to transforming growth factor β growth inhibition in p16INK4A(−) human mammary epithelial cells , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[51] J W Gray,et al. The ZNF217 gene amplified in breast cancers promotes immortalization of human mammary epithelial cells. , 2001, Cancer research.
[52] F. Christians,et al. E2Fs regulate the expression of genes involved in differentiation, development, proliferation, and apoptosis. , 2001, Genes & development.
[53] Thea D. Tlsty,et al. Normal human mammary epithelial cells spontaneously escape senescence and acquire genomic changes , 2001, Nature.
[54] P. J. Welch,et al. Identification of Id4 as a regulator of BRCA1 expression by using a ribozyme-library-based inverse genomics approach. , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[55] Y. Cong,et al. Histone Deacetylation Is Involved in the Transcriptional Repression of hTERT in Normal Human Cells* , 2000, The Journal of Biological Chemistry.
[56] A. Iavarone,et al. Id2 is a retinoblastoma protein target and mediates signalling by Myc oncoproteins , 2000, Nature.
[57] T. Rohan,et al. Role of the insulin-like growth factor family in cancer development and progression. , 2000, Journal of the National Cancer Institute.
[58] Christian A. Rees,et al. Molecular portraits of human breast tumours , 2000, Nature.
[59] C. Deng,et al. Roles of BRCA1 and its interacting proteins , 2000, BioEssays : news and reviews in molecular, cellular and developmental biology.
[60] E. Lander,et al. Expression analysis with oligonucleotide microarrays reveals that MYC regulates genes involved in growth, cell cycle, signaling, and adhesion. , 2000, Proceedings of the National Academy of Sciences of the United States of America.
[61] M. Yutsudo,et al. Sp1 cooperates with c-Myc to activate transcription of the human telomerase reverse transcriptase gene (hTERT). , 2000, Nucleic acids research.
[62] J. Mesirov,et al. Molecular classification of cancer: class discovery and class prediction by gene expression monitoring. , 1999, Science.
[63] P. Yaswen,et al. Viral oncogenes accelerate conversion to immortality of cultured conditionally immortal human mammary epithelial cells , 1999, Oncogene.
[64] B. Williams,et al. Identification of genes differentially regulated by interferon α, β, or γ using oligonucleotide arrays , 1998 .
[65] D. Botstein,et al. Cluster analysis and display of genome-wide expression patterns. , 1998, Proceedings of the National Academy of Sciences of the United States of America.
[66] A. Brenner,et al. Increased p16 expression with first senescence arrest in human mammary epithelial cells and extended growth capacity with p16 inactivation , 1998, Oncogene.
[67] J. Herman,et al. Alterations in DNA methylation: a fundamental aspect of neoplasia. , 1998, Advances in cancer research.
[68] B. Williams,et al. Identification of genes differentially regulated by interferon alpha, beta, or gamma using oligonucleotide arrays. , 1998, Proceedings of the National Academy of Sciences of the United States of America.
[69] P. Yaswen,et al. Gradual phenotypic conversion associated with immortalization of cultured human mammary epithelial cells. , 1997, Molecular biology of the cell.
[70] F. Miller,et al. Transforming and oncogenic potential of activated c-Ha-ras in three immortalized human breast epithelial cell lines. , 1997, Anticancer research.
[71] R. Weinberg,et al. hEST2, the Putative Human Telomerase Catalytic Subunit Gene, Is Up-Regulated in Tumor Cells and during Immortalization , 1997, Cell.
[72] J. Geradts,et al. High frequency of aberrant p16(INK4A) expression in human breast cancer. , 1996, The American journal of pathology.
[73] M. Stampfer,et al. Insulin receptor overexpression in 184B5 human mammary epithelial cells induces a ligand‐dependent transformed phenotype , 1995, Journal of cellular biochemistry.
[74] H. Soule,et al. Characterization of epithelial phenotypes in mortal and immortal human breast cells , 1992, International journal of cancer.
[75] M. Kraus,et al. Oncogenic potential of erbB-2 in human mammary epithelial cells. , 1991, Oncogene.
[76] F. McCormick,et al. Transformation of human mammary epithelial cells by oncogenic retroviruses. , 1988, Cancer research.
[77] M. Stampfer,et al. Induction of transformation and continuous cell lines from normal human mammary epithelial cells after exposure to benzo[a]pyrene. , 1985, Proceedings of the National Academy of Sciences of the United States of America.
[78] S. L. Hammond,et al. Serum-free growth of human mammary epithelial cells: rapid clonal growth in defined medium and extended serial passage with pituitary extract. , 1984, Proceedings of the National Academy of Sciences of the United States of America.